USPTO Deadlines
Next Deadline
49 days remaining
Final Refusal E-Mailed
Due Date
December 22, 2025
Extension Available
Until March 22, 2026
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 30, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 30, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 29, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 29, 2025 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Sep 22, 2025 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Sep 22, 2025 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Sep 22, 2025 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Aug 26, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 26, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 26, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 4, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 4, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 4, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 4, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 3, 2025 | TAEA | I | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | Loading... |
| Mar 3, 2025 | TAEA | I | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | Loading... |
| Mar 3, 2025 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Feb 28, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Feb 28, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 28, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Vaccine adjuvants; Adjuvants for use with vaccines; Adjuvants for medical purposes; Herbal supplements; Oral vaccine preparations; Adjuvants for veterinary purposes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Plant and herb extracts, other than essential oils, for medicinal purposes; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Human vaccine preparations; Herbal extracts, other than essential oils, for medical purposes; Adjuvants for veterinary use; Veterinary vaccines
First Use Anywhere:
Dec 13, 2022
First Use in Commerce:
Mar 15, 2023
Additional Information
Pseudo Mark
Q VANT BIOSCIENCES
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOSCIENCES"